| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.0034 |
1 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |